1. Signaling Pathways
  2. Membrane Transporter/Ion Channel
  3. Ferlin Family

Ferlin Family

Ferlin Family

The Ferlin protein family consists of proteins containing C2 domains, which play a key role in vesicle fusion and membrane transport. Mammals have six Ferlin proteins (Fer1L1-6), namely Dysferlin (DYSF), Otoferlin (OTOF), Myoferlin (MYOF), Fer1L4 (Ferlin 4), Fer1L5 (Ferlin 5), and Fer1L6 (Ferlin 6). These are classified into two categories based on the presence or absence of the DysF and FerA domains: Class I (containing DysF and FerA) and Class II (lacking DysF and FerA).
Ferlin proteins participate in intracellular vesicle transport and membrane repair processes through interactions with cytoskeletal motor proteins, other vesicle-related transport proteins, and transmembrane receptors or channels. They regulate vesicle fusion under the control of calcium signaling, affecting neurotransmission and receptor recycling. These proteins are associated with various signaling pathways, including intracellular calcium regulation and vesicle dynamics. For example, Dysferlin is directly involved in calcium-activated membrane repair, while Otoferlin is crucial for calcium-activated release of neurotransmitter vesicles in auditory transmission. Dysfunction of Ferlin proteins can lead to diseases such as muscular dystrophy and hearing loss. For instance, defects in Dysferlin cause progressive muscular dystrophy, while defects in Otoferlin are associated with non-syndromic hearing loss[1].

Ferlin Family Related Products (1):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-143657
    Myoferlin inhibitor 1
    99.88%
    Myoferlin inhibitor 1 is a compound that exhibits reversible, concentration-dependent binding to the myoferlin MYOF-C2D protein, with a KD of 0.094 μM. Myoferlin inhibitor 1 shows potent anti-invasion and anti-migration activities against different pancreatic cancer cells. Myoferlin inhibitor 1 inhibits pancreatic cancer metastasis through reversing mesenchymal transition (EMT), inhibiting the secretions of MMP1 and MMP2 and blocking the receptor tyrosine kinases. Myoferlin inhibitor 1 displays effective antimetastatic activities in pancreatic cancer in vitro and in vivo. Myoferlin inhibitor 1 can be used in research on preventing pancreatic cancer metastasis.
    Myoferlin inhibitor 1